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Multiple sclerosis (MS), optic neuritis (ON), transverse myelitis (TM), clinically 
isolated syndrome (CIS), Devic disease, and acute disseminated encephalomyelitis 
(ADEM) are collectively known as acquired demyelinating syndrome (ADS) (1). 
In children, ADS is rare with unknown prevalence, but its incidence is increasing. 
Few studies have addressed the incidence of pediatric ADS. A study from Canada 
showed incidence of 0.9 per 100,000 with 43% MS, 22% ADEM, 23% ON, and 
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Incidence of CNS acquired demyelinating syndrome (ADS), especially multiple 
sclerosis (MS) in children, appears to be on the rise worldwide. The objective 
of this study was to determine prevalence, clinical presentation, neuroimaging 
features, and prognosis of different types of ADS in Iranian children.
Materials & Methods
During the period 2002-2012, all the patients (aged 1-18 years) with ADS, such 
as MS, acute disseminated encephalomyelitis (ADEM), optic neurotic (ON), 
Devic disease, and transverse myelitis (TM), referred to the pediatric neurology 
ward, Nemazee Hospital, Shiraz University of Medical Sciences, were included 
in this study. Demographic data, clinical signs and symptoms, past and family 
history, preclinical findings, clinical course, and outcome were obtained. 
Results
We identified 88 patients with ADS in our center. The most prevalent disease was 
MS with 36.5% (n=32), followed by AEDM 26.1% (n=31), ON 17% (n=13), 
TM 15.9% (n=14), and Devic disease 4.5% (n=4). MS, ON, TM were more 
common among females while ADEM was more common in males. Children 
with ADEM were significantly younger than those with other types of ADS. 
Family history was positive in 10% of patients with MS. 
Previous history of recent infection was considerably seen in cases with ADEM. 
Clinical presentation and prognosis in this study was in accordance with those 
in previous studies on children. 
Conclusion
In this study, the most common type of ADS was MS, which was more common 
in female and older age cases. ADEM was more common in male and younger 
children. ADEM and ON had the best and Devic disease had the worst prognosis.
Keywords: CNS demyelinating syndrome; Multiple sclerosis; Optic neuritis; 
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22% TM (2).
MS is the most prevalent of such diseases in adults. 
It is a chronic debilitating disease that mostly involve 
young adult. Its prevalence is 75 per 100,000 population 
in USA and 40 per 100,000 populations in Iran. About 
5% of adults who develop MS had their first attack in 
childhood (3-5). Etiology of ADS is unknown, but 
genetic and environmental factors are influential in the 
pathogenesis of the disease (6).
According to literature, most of the studies have been 
conducted in European countries. Reported data from 
Asia and, especially on Iranian children are very limited. 
The aim of this study was to determine the prevalence of 
different types of ADS, clinical and paraclinical findings, 
and their outcomes in the studied population.
Materials & Methods
In this prospective cross-sectional study, we assessed all 
children aged 1-18 years with criteria of ADS, referred 
to pediatric neurology ward, Nemazee Hospital, Shiraz, 
Iran during 2002- 2012. This hospital serves as the 
referral center in south of Iran. Diagnosis of all types of 
ADS (MS, ADEM, ON, TM, and Devic disease) was 
based on the consensus definition for pediatric ADS 
(5,7). Inclusion and exclusion criteria are summarized 
in Table 1 (8).
A questionnaire on demographic features, clinical 
sign and symptoms, recent history of infection and 
vaccination, family history of ADS, paraclinical 
findings (laboratory, brain MRI), and clinical course 
and prognosis, was filled in for each patients based on 
respective medical records.
The collected data were analyzed by SPSS software 
(version 19). Inferential statistics including correlation 
and Mann-Whitney test and descriptive statistics, 
including central and dispersion tendencies were used. 
P-value less than 0.05 was considered statistically 
significant. Informed consents were obtained from 
patients or their parents. The study design was approved 
by the Ethics Committee of Shiraz University of Medical 
Sciences. 
Results
We identified 88 patients with ADS in our study. Annual 
incidence of ADS in Fars province is about 0.19 per 
100.000 persons consisting of 59.1% females and 40.9% 
males. The most prevalent disease was MS with 36.5% 
(n=32), followed by ADEM 26.1% (n=23), ON 17% 
(n=15), TM 15.9% (n=14), and Devic disease 4.5% 
(n=4). The age of patients ranged between 1 and 18 
years with mean of 12±4.8 years, and the mean age of 
onset of symptoms was 11±4.71 years. The mean age for 
Devic cases was the highest (16.3 years), and for ADEM 
was the lowest (7.6 years) (Table 2).
Female to male ratio in MS cases was 3/1, in ADEM 1/2, 
and in ON 2/1. The Most common presenting feature 
was visual impairment (51.1%), followed by paraplegia 
(37.5%), ataxia (28.4%), and impaired consciousness 
(23.9%) (Table 3). 
Most frequent season of presentation of patients was 
autumn (31.8) and the least was in spring (11.4%). It was 
observed that 41 cases of ADS (46.6%) had a history of 
recent infection, of whom patients with ADEM showed 
the highest rate of positive recent infection (73%). 
Positive family history of demyelination disease was 
about 10%, all being with MS (Table 2).
Most common presenting features in patients with MS 
were visual impairment, ataxia, and paresthesia, and 
in ADEM cases were impaired level of consciousness, 
paraplegia, and seizure (Table 3). Eighty (80%) patients 
had brain and spinal cord MRI. The most common 
findings of the brain imaging are shown in (Table 4). 
Visual evoked potential (VEP) was done in 66 patients, 
of whom 29 (33%) were abnormal, mostly in those 
with ON and MS. Fifty-nine patients underwent lumbar 
puncture, of whom 26 (30%) had mild pleocytosis with 
increased protein.
Vasculitis serology work-up was done for 66 patients, of 
whom 4 patients were found to be positive for antinuclear 
antibody (ANA), all of them were in MS group. Of 32 
patients with MS, 28 received follow-up, and all had 
EDSS (expanded disability status scale) score below 4, 
indicating minimal disability.
Recurrent disease occurred in 22 (25%) patients 
consisting of 17 with MS, 2 with ON, 1 with ADEM, 
and 2 with Devic disease. In cases with ADEM, 1 patient 
expired, 2 patients had mild disability in the follow-up, 
and others had complete recovery. Among 15 patients 
with ON, 3 had mild visual impairment, 14 had complete 
recovery, and 1 developed MS after 3 years. Seven (50%) 
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patients with TM had complete recovery, 2 had mild 
motor disability, 3 had severe motor disability (complete 
paralysis), and 3 had mild sphincter dysfunction. In 
follow-up, from 4 patients with Devic disease, 2 had 
multiple recurrences, 1 had blindness with paralysis, 1 
patient developed blindness, and 1 had paralysis. 
Discussion
According to the results of the present study, annual 
incidence of ADS in Fars province is about 0.19 per 
100.000 persons. It is low in comparison with the rate in 
Canadian study, which was 0.9 per 100.000 children and 
in South California, which was 1.66 per 100.000 persons 
(1,2). Probably, all children with ADS were not referred 
to our center and some of them had been followed by 
adult neurologist or ophthalmologist. MS was the most 
common type of ADS in the present study (32%), which 
is consistent with the rates reported from UK, Ireland, 
and US (about 31%) (1,8). However, ON was the most 
common among Canadian children 23% (2). 
Female to male ratio in this study was 1.4:1, consistent 
with that of Canadian study (1.09:1) and UK (1.3:1), 
but different from a study by Etemadifar in Iran (4.5:1) 
(12). Female to male ratio in patients over 10 years old 
was 1.6:1 and it was 1.1:1 in those under 10 years. In 
agreement with other studies, it was found that MS, ON, 
and TM were more common in females and ADEM was 
more common in males (1).
Similar to other studies, we found that MS is polyphasic 
but ADEM is mostly monophasic and more common in 
males, and patients are under 10 years of age (1,2,7,9). 
Most common season of presentation of ADS in the 
present study was autumn, but it was spring in the studies 
by Jin et al. and Ghobai et al. (10,11).
Regarding positive family history, the rate of MS in 
children was reported to be 0-21% (12-15) and it was 
10% in the present study and 9% in another study from 
Iran (12). History of recent infection was positive in 
46.5% of our patients, mostly in ADEM cases.
In this study, the most common presenting feature of MS 
was visual impairment followed by ataxia. Decreased 
level of consciousness, seizure, and paraplegia, were 
the most frequent features in ADEM cases, consistent 
with other studies (12,16-18). Autoantibody such as 
antinuclear antibody (ANA) was positive in 4 (12%) 
patients with MS, other studies reported it to be 22.5% 
to 26.7% in adult population with MS (19,20).
According to clinical course and outcome, EDSS score 
of MS patients in our study was less than 4, which has 
been also reported in some previous studies (12,13). 
Prognosis of ON in our patients was good and 82% had 
complete recovery, while only 1 patient developed MS 
in follow-up, similar to other reports in children (21,22). 
As revealed in the present study, 50% of TM patients had 
complete recovery, 14% had mild disability, 20% were 
wheel chair dependent and 20% developed persistent 
bladder dysfunction. Similarly, in a study by Thomas, 
16% were wheel chair dependent and 22% had bladder 
dysfunction (23). 
Given the increasing rate of ADS in Iranian children, 
developing a registration system for such patients is 
suggested in order to obtain more accurate information 
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(1) A polysymptomatic clinical event with acute/subacute onset that must include encephalopathy 




A first acute-clinical episode of CNS symptoms which may either be monofocal or multifocal, but 
does not include encephalopathy (except in brainstem syndromes). The MRI will show white matter 
demyelination. These include: 
1. Transverse myelitis (TM): weakness and/or numbness of both legs +/- arms, usually with maximal 
deficits 1 week after symptom onset supported by demyelination on MRI spine. 
2. Optic neuritis: Acute or subacute loss of vision and ≥1 of: relative afferent pupillary defect (unilateral 
cases), visual field deficit or scotoma, impaired colour vision, optic disc edema, or abnormal visual 
evoked potentials. MRI is not necessary for diagnosis. 




Must have: i. Optic neuritis and ii. Acute myelitis. 
Must have: iii. Spinal MRI lesion extends over three or more segments or iv. Aquaporin-4 antibody 
testing is positive. 
The brain MRI may be abnormal but must not meet Multiple Sclerosis MRI diagnosis criteria.
Exclusion criteria
1. Leukodystrophies (e.g. metachromatic leukodystrophy, adrenoleukodystrophy) or mitochondrial 
disease. 
2. Proven CNS infection (e.g. viral encephalitis, bacterial meningitis, herpes simplex encephalitis, Lyme 
disease, HIV). 
3. Radiation/chemotherapy associated white matter damage. 
4. Condition fulfilling criteria for CNS connective tissue disease e.g. lupus, vasculitis. The sole presence 
of antibodies associated with CNS connective tissue or autoimmune diseases was not sufficient for 
exclusion.
Table 2. Demographic characteristic of pediatric ADS cases
MS ADEM ON TM Devic Total 
Frequency 32 23 15 14 4 88
Mean age 13.8 7.6 11.6 13.2 16.3 12
Female/ male 24/8 8/15 10/5 8/6 2/2 52/36
Positive family history 8 0 0 0 0 8
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Table 3. Frequency of the first clinical symptoms in patients with ADS
                Disease
Symptoms
Devic ADEM MS ON TM
Ataxia 2 5 12 4 2
Speech disorders 0 3 4 0 0
Hemiplegia 0 0 7 0 1
Decreased LOC 0 15 3 3 0
Convulsion 1 7 1 1 0
Visual disturbances 4 4 20 15 2
Paraplegia 3 9 7 1 13
Sphincter dysfunction 1 3 3 0 10
Sensory symptoms 4 1 11 1 10
Vertigo 0 0 5 4 0
Headache 0 6 4 9 0
Diplopia 0 0 1 0 0
Vomiting 0 0 1 0 0
Table 4. MRI findings in patients with ADS 
MRI finding (site of involvement) Number Percent 
Croups callosum 6 6.8
Brain stem 9 10.2
Spinal cord 29 32.9
Cerebellum 10 11.4
Deep white matter 43 48.9
Internal capsule 5 5.7
Basal ganglia 2 2.3
Thalamus 6 6.8
Optic nerve 6 6.8
Normal MRI 8 9.1
23Iran J Child Neurol. 2014 Spring Vol 8 No 2 
Acquired CNS Demyelinating Syndrome in Children
References
1. Longer-Gould A, Zhaug JL, Chung J, Yeung Y, Wanbant 
E, Yao J. Incidence of acquired CNS demyelinating 
syndrome in a multiethnic cohort of children. Neurology 
2011;27(12):1143-8.
2. Banwell B, Kennedy J, Sandovnick D, Arnold DL, 
Magalhaes S, Wambera K. Incidence of acquired 
demyelination of the CNS in Canadian children. 
Neurology 2009;72(3):232-9.
3. Canellas AR, Gols AR, Izquierdo J.R, Subirana MT, Gairin 
XM. Idiopathic inflammatory demyelinating disease of 
central nervous system. Neuroradiology 2007;49(5):393-
409.
4. Renoux C, Vukusic S, Mikaeloff Y. Natural history of 
multiple sclerosis with childhood onset. N Engl Med 
2007;356(25):2603-13.
5. Krupp LB, Banwell B, Tenembaum S; International 
Pediatric MS Study Group. Consensus definition proposed 
for pediatric multiple sclerosis and related disorders. 
Neurology 2007;68(16 Suppl 2):S7-12.
6. Ebers GC. Environmental factors and multiple sclerosis. 
Lancet Neurol 2008;77(3):268-77.
7. Banwell B, Ghezzi A, Bar-OrA, Mikaeloff Y, Tordieu 
M. Multiple sclerosis in children, clinical diagnosis, 
therapeutic strategies and future directions. Lancet Neurol 
2007;6(10):887-902.
8. Absound M, Lim MJ, Chorg Wk, Goede CGs Foster K, 
Counny R. Pediatric acquired demyelinating syndromes: 
incidence, clinical and magnetic resonance imaging 
features. Mult Scler 2012;19(1):76-86.
9. Banwell B, Krupp L, Kennedy J. Clinical features 
and viral serology in children with multiple sclerosis: 
a multinational observation study. Lancet Neurology 
2007;6(9):773-81.
10. Jin Y, Depedro-Cusesta J, Söderströ, M. Stawiarz L, 
Link H. Seasonal pattern in optic neuritis and multiple 
sclerosis. A meta-analysis. J Neurol Sci 2000;1(181):56-
64.
11. Ghobai M, Omrani H, Rostaئzadeh M. Epidemiology of 
multiple sclerosis. Tehran Univ Med J 2008;65:74-7.
12. Etemadifar M, Hosseini A, Khodabanehlou R, Maghzi AH. 
Childhood-onset multiple sclerosis: report of 82 patients 
from Esfahan, Iran. Arch Iranian Med 2007;10(2):152-6.
13. Ruggior M, Polizzi A, Pervon L, Grimoldi LM. Multiple 
sclerosis in children under 6 years of age. Neurology 
1999;53(3):478-4.
14. Handefield FA. Characteristic of childhood multiple 
sclerosis. Int MS J 1995;3:91-8.
15. Selcen D, Anlar B, Renda Y. Multiple sclerosis in children. 
Report of 16 cases. Eur Neurol 1996;36(2):79-84.
16. Inaloo S, Yavari MJ, Sabori S. Multiple sclerosis in 
children: A review of clinical and paraclinical features in 
26 cases. Iran J Child Neruol 2008;2(4):41-6.
17. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey 
AS, Kean MJ. Clinical and Neuroradiologic feature 
of acute disseminated encephalomyelitis in children. 
Neurology 2001;56(13):8-12.
18. Murthy KSN, Faden HS, Cohen ME, Bakshi R. Acute 
disseminated encephalomyelitis in children. Pediatric 
2002;110(2):1-8.
19. Collard RC, Koehler RP, Mattson DH. Frequency 
and significance of antinuclear antibodies in multiple 
sclerosis. Neurology 1997;49(3):857-61.
20. Barned S, Goodman AD, Mattson AD. Frequency of 
antinuclear antibodies in multiple sclerosis. Neurology 
1995;45(2):384-5.
21. Sri-Udomkajorn S, Pongwatcharaporn K. Clinical feature 
and outcome of childhood optic neuritis at Queen Sirikit 
National Institute of Child Health. J Med Assoc Thai 
2011;94(Suppl 3):S189-94.
22. Absoud M, Cummins C, Desai N, Gika A, McSweeney N, 
Munot P, et al. Childhood optic neuritis clinical features 
and outcome. Arch Dis Child 2011;96(9):860-2.
23. Thomas T, Branson HM, Verhey LH, Shroff M, Stephens 
D, Magallhaes S, et al. The demographic, clinical, and 
magnetic resonance imaging (MRI) features of transverse 
myelitis in children. J Child Neurol 2012;27(1):11-21.
